MyoKardia, Inc. (MYOK): Price and Financial Metrics


MyoKardia, Inc. (MYOK)

Today's Latest Price: $61.27 USD

0.21 (-0.34%)

Updated Feb 28 12:12pm

Add MYOK to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MYOK Stock Summary

  • With a price/sales ratio of 283.62, MyoKardia Inc has a higher such ratio than 98.98% of stocks in our set.
  • Over the past twelve months, MYOK has reported earnings growth of 292.69%, putting it ahead of 95.71% of US stocks in our set.
  • As for revenue growth, note that MYOK's revenue has grown -53.7% over the past 12 months; that beats the revenue growth of just 3.04% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MyoKardia Inc are TRVN, MNTA, NBRV, NVCN, and INFI.
  • MYOK's SEC filings can be seen here. And to visit MyoKardia Inc's official web site, go to www.myokardia.com.
MYOK Daily Price Range
MYOK 52-Week Price Range

MYOK Stock Price Chart More Charts


MYOK Price/Volume Stats

Current price $61.27 52-week high $78.28
Prev. close $61.48 52-week low $44.01
Day low $59.99 Volume 190,198
Day high $62.52 Avg. volume 363,868
50-day MA $70.23 Dividend yield N/A
200-day MA $58.07 Market Cap 2.83B

MyoKardia, Inc. (MYOK) Company Bio


MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases


MYOK Latest News Stream


Event/Time News Detail
Loading, please wait...

MYOK Latest Social Stream


Loading social stream, please wait...

View Full MYOK Social Stream

MYOK Price Returns

1-mo -12.66%
3-mo -5.96%
6-mo 13.95%
1-year 36.61%
3-year 404.28%
5-year N/A
YTD -15.94%
2019 49.17%
2018 16.06%
2017 225.10%
2016 -11.66%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8489 seconds.